Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

NASDAQ:GILD

Overview | Financials
Company Name Gilead Sciences, Inc.
Symbol GILD
Currency USD
Price 111.44
Market Cap 138,781,804,000
Dividend Yield 4.46%
52-week-range 62.07 - 119.96
Industry Drug Manufacturers—General
Sector Healthcare
CEO Mr. Daniel P. O'Day
Website https://www.gilead.com

An error occurred while fetching data.

About Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use,

Related Stocks

Intuitive Surgical, Inc. logo

Intuitive Surgical, Inc.

ISRG

484.44 USD

Regeneron Pharmaceuticals, Inc. logo

Regeneron Pharmaceuticals, Inc.

REGN

666.87 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

504.77 USD

Moderna, Inc. logo

Moderna, Inc.

MRNA

34.62 USD

Illumina, Inc. logo

Illumina, Inc.

ILMN

85.6 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

11.23 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

415.3 USD

Biogen Inc. logo

Biogen Inc.

BIIB

139.44 USD

Financials

Numbers are in millions USD

Numbers are in millions USD